
Asst Professor Adv HF and Transplant Cardiology. HCM, Inherited CM, HT, MCS. At @UTSWMedCenter via @Stanford_HF, @UChicagoMed, @CWRUSom, @NorthwesternU
Joined November 2018
- Tweets226
- Following1.6K
- Followers793
- Likes781
Natalie Tapaskar retweeted
New in JACC: Heart Failure — "Defining Clinically Meaningful Within-Patient Changes in Heart Failure"
A statistically significant trial result doesn't always mean something to the patient in front of you. This paper tries to close that gap. 🧵
Natalie Tapaskar retweeted
Our position statement on clinically meaningful differences in patient outcomes is out! Thankful for everyone who was part of this work! @JACCJournals
@AndrewPAmbrosy @JavedButler1 @BiykemB @noshreza @jspertus @NatalieTapaskar @hfcollaboratory @ACCinTouch
jacc.org/doi/10.1016/j.jchf.…
Natalie Tapaskar retweeted
Top Things to Know from our @AHAScience Scientific Statement on Standardization of Hemodynamic testing out today! @FudimMarat
Thank you to @NatalieTapaskar for putting this together!
professional.heart.org/en/sc…
Natalie Tapaskar retweeted
#ESCCongress #HOTLINE 2
MAPLE-HCM w/ impressive results presented by @dr_pavia
Are we headed to CMI as 1st line therapy for LVOTO⁉️
Aficamten was superior to Metoprolol in the primary endpoint of ⬆️pVO2 and ALL sec endpoints (NYHA, KCCQ, NTproBNP, LVOTO).
Enhorabuena Pablo!
Natalie Tapaskar retweeted
#ESCCongress HOTLINE 2️⃣
ODYSSEY-HCM failed to reach its primary endpoint of increase in KCCQ and peak VO2 in non-obstructive #HCM
Subgroup analysis suggest potential benefit
▶️ younger patients
▶️ less advanced disease and shorter duration of disease
▶️ less diastolic dysfunction – at Madrid, Spain
Natalie Tapaskar retweeted
🔮The future of🫀xplant surveillance? Cell-free🧬‼️
4⃣ abstracts from SHORE #WTC2025 in 1⃣ session:
👉HLA1/HLA2
👉longitudinal trends
👉AMR
👉Persistent elevation
@tcccop @AST_info @amjtransplant @CareDx
@KiranKhush1 @UChicagoCardio @ajay_vaidya @amitalamMD @Richardkcheng2
Natalie Tapaskar retweeted
What do we know about using beta blockers in HFpEF? Turns out not a whole lot. Need more definitive withdrawal RCTs to answer this fundamental question jamanetwork.com/journals/jam…
Natalie Tapaskar retweeted
The 2025 Heart Failure Symposium is around the corner, and we are proud to announce that the course has been officially endorsed by the Heart Failure Society of America. Join us on May 10: bit.ly/2025-HF-Symposium
Natalie Tapaskar retweeted
💗@Stanford_HF's incredible HF trainees past & future, along with our fabulous team at @ISHLT‼️
@KiranKhush1 @MartaFarrero @LuPoten @SunnyVMD @ErikHenricksen @JamalMaharH @NatalieTapaskar @3rdheartsound @brian_wayda @jukakimMD @StanfordCVI @StanCVFellows #ISHLT2025
Super fun heart failure consult week at Parkland with trainees at all levels! Impressed by the thoughtful care delivered by these fantastic future cardiologists! @ayeeshik @GailPetersonMD @UTSWCardfellow @UTSWIMchief
Grateful for the past 4 years at Stanford! Thank you AHFTC team for the mentorship - @KiranKhush1 @JeffTeuteberg @EldrinL @SunnyVMD, my awesome co-fellows @JamalMaharH and @alyelezaby and so many others over the years! Can’t wait for the next step!
Natalie Tapaskar retweeted
Incredibly proud of our graduating @Stanford_HF fellows @JamalMaharH @NatalieTapaskar @alyelezaby. It’s been an amazing year and we can’t wait to see what you accomplish next! @JeffTeuteberg @EldrinL
Natalie Tapaskar retweeted
🚨1st SHORE pub‼️ > 2k🫀transplants, dual non-invasive rejection surveillance with GEP & dd-cfDNA:
1. ⬆️yield for ACR over either test alone
2. ⬇️number of biopsies
3. Great survival and🫀LVEF
@KiranKhush1 @TheJHLT @ISHLT @AST_info @HFSA @NirUrielMD
jhltonline.org/article/S1053…
Natalie Tapaskar retweeted
🚨New @CardioNerds episode alert 🚨
Join @Dr_DanMD, episode chair @dinubalanescu, and FIT lead @NatalieTapaskar to learn about heart failure in CardioOncology from expert Dr. Richard Cheng
cardionerds.com/370-cardioon…
Natalie Tapaskar retweeted
Will this be the silver bullet to end with EMB as the gold-standard for post-HT monitoring? Results from the #SHORE registry show that the combination of GEP + dd-cfDNA is better associated with post-HT outcomes than EMB. Congrats all the authors for this amazing work #ishlt2024
Natalie Tapaskar retweeted
Excited to share findings from the #DanGer trial #ACC24 from Jacob Moller @CardioNerds #cardiogenicshock #ImpellaCS
🫀international, multicenter, randomized trial
🫀patients with STEMI and cardiogenic shock were assigned to Impella CP vs standard care only #NEJM
Natalie Tapaskar retweeted
#CardiogenicShock in #Pregnancy warrants attention
🏷️⬆️ morbidity & mortality
🏷️ ⬇️ fetal outcomes
🏷️ Sparse data
Moderated by @DhariniRamu @JasonKatzMD
Great talks by @NatalieTapaskar @JessSchultzMD @docbhardwaj @IRajapreyar #RajivGulati #ACC24
@shelleyhallmd @KatAAClark













































